During the past decade, Allergy & Asthma Research Center of El Paso conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Research Center of El Paso" are "Asthma" (2 trials). Many other conditions were trialed in "Allergy & Asthma Research Center of El Paso" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Research Center of El Paso" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (2 trials), "Placebo" (2 trials) and "Standard of Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Research Center of El Paso" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Asthma Research Center of El Paso". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Allergy & Asthma Research Center of El Paso, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Research Center of El Paso, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".